[Integrated Care Protocol: Prevention, diagnosis and treatment of diabetes mellitus 2].

Select Content Type
Clinical Guidelines
Authored By
Medina-Chávez JH, Vázquez-Parrodi M, Mendoza-Martínez P, Ríos-Mejía ED, de Anda-Garay JC, Balandrán-Duarte DA
Authored On
Interests
Endocrinology
Internal/Family Medicine
Speciality
Endocrinology
Internal/Family Medicine
Book Detail
volume
60
ISSN
2448-5667
Publication Date
Actions
Download in App
Event Data
{"article_title":"[Integrated Care Protocol: Prevention, diagnosis and treatment of diabetes mellitus 2].","author":"Medina-Ch\u00e1vez JH, V\u00e1zquez-Parrodi M, Mendoza-Mart\u00ednez P, R\u00edos-Mej\u00eda ED, de Anda-Garay JC, Balandr\u00e1n-Duarte DA","journal_title":"Revista medica del Instituto Mexicano del Seguro Social","issn":"2448-5667","isbn":"","publication_date":"2020 Mar 23","volume":"60","issue":"Supl 1","first_page":"S4","page_count":"","accession_number":"35135039","doi":"","publisher":"Coordinacio\u0301n de Educacio\u0301n en Salud, Divisio\u0301n de Innovacio\u0301n Educativa","doctype":"Journal Article","subjects":"Mexico; Delivery of Health Care, Integrated; Diabetes Mellitus, Type 2 diagnosis; Diabetes Mellitus, Type 2 prevention & control; Humans; Mexico","interest_area":["Endocrinology"," Internal Medicine"],"abstract":"Background: Type 2 diabetes mellitus (DM2) represents one of the ten non- transmissible chronic diseases that constitute the main causes of death and disability in Mexico. It is the leading cause of disability and the second cause of death. The IMSS serves 4.2 million people living with this disease. Objective: Establish lines of action that allow standardizing the substantive activities to be carried out by the multidisciplinary health team, promoting healthy lifestyles, establishing timely diagnoses, providing adequate and intensified care and treatments, preventing complications, and providing comprehensive care and of quality for the benefit of the beneficiaries. Material and Methods: The process of development of the Integrated Care Protocols consisted of: 1) Prioritization of the health problem, 2) Conformation of an interdisciplinary work group, 3) Development of content and systematic search for information 4) Analysis, review and discussion of interventions, 5) Review and validation by regulatory areas, 6) Dissemination and implementation. Conclusions: Promotion and prevention actions must be carried out at all levels and by all health personnel, likewise, the incorporation of new treatments for DM2 in the IMSS, requires the homologation of the criteria in risk stratification, diagnosis, profile risk of hypoglycemia and adverse effects to limit the complications of the disease and reduce the burden of disease (disability and premature death). \u00a9 2022 Revista Medica del Instituto Mexicano del Seguro Social.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=35135039&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Medina-Ch\u00e1vez JH, V\u00e1zquez-Parrodi M, Mendoza-Mart\u00ednez P, R\u00edos-Mej\u00eda ED, de Anda-Garay JC, Balandr\u00e1n-Duarte DA","Journal_Info":"Publisher: Coordinacio\u0301n de Educacio\u0301n en Salud, Divisio\u0301n de Innovacio\u0301n Educativa Country of Publication: Mexico NLM ID: 101243727 Publication Model: Electronic Cited Medium: Internet ISSN: 2448-5667 (Electronic) Linking ISSN: 04435117 NLM ISO Abbreviation: Rev Med Inst Mex Seguro Soc Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2022-02-07","Source":"Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2022 Feb 07; Vol. 60 (Supl 1), pp. S4-S18. Date of Electronic Publication: 2022 Feb 07.","Languages":"Spanish; Castilian","Electronic_ISSN":"2448-5667","MeSH_Terms":"Delivery of Health Care, Integrated* , Diabetes Mellitus, Type 2*\/diagnosis , Diabetes Mellitus, Type 2*\/prevention & control, Humans ; Mexico","Subjects":"Humans, Mexico, Delivery of Health Care, Integrated, Diabetes Mellitus, Type 2 diagnosis, Diabetes Mellitus, Type 2 prevention & control","Title_Abbreviations":"Revista medica del Instituto Mexicano del Seguro Social","Volume":"60"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"35135039","RelevancyScore":"915","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"914.587707519531"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35135039&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35135039&authtype=shib&custid=ns346513&group=main&profile=eds"}
ISSN
2448-5667
IS_Ebsco
true
Additional Info
["Medina-Ch\u00e1vez JH, V\u00e1zquez-Parrodi M, Mendoza-Mart\u00ednez P, R\u00edos-Mej\u00eda ED, de Anda-Garay JC, Balandr\u00e1n-Duarte DA","Publisher: Coordinacio\u0301n de Educacio\u0301n en Salud, Divisio\u0301n de Innovacio\u0301n Educativa Country of Publication: Mexico NLM ID: 101243727 Publication Model: Electronic Cited Medium: Internet ISSN: 2448-5667 (Electronic) Linking ISSN: 04435117 NLM ISO Abbreviation: Rev Med Inst Mex Seguro Soc Subsets: MEDLINE","Journal Article; Practice Guideline","2022-02-07","Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2022 Feb 07; Vol. 60 (Supl 1), pp. S4-S18. Date of Electronic Publication: 2022 Feb 07.","Spanish; Castilian","2448-5667","Delivery of Health Care, Integrated* , Diabetes Mellitus, Type 2*\/diagnosis , Diabetes Mellitus, Type 2*\/prevention & control, Humans ; Mexico","Humans, Mexico, Delivery of Health Care, Integrated, Diabetes Mellitus, Type 2 diagnosis, Diabetes Mellitus, Type 2 prevention & control","Revista medica del Instituto Mexicano del Seguro Social","60"]
Description

Background: Type 2 diabetes mellitus (DM2) represents one of the ten non- transmissible chronic diseases that constitute the main causes of death and disability in Mexico. It is the leading cause of disability and the second cause of death. The IMSS serves 4.2 million people living with this disease.<br />Objective: Establish lines of action that allow standardizing the substantive activities to be carried out by the multidisciplinary health team, promoting healthy lifestyles, establishing timely diagnoses, providing adequate and intensified care and treatments, preventing complications, and providing comprehensive care and of quality for the benefit of the beneficiaries.<br />Material and Methods: The process of development of the Integrated Care Protocols consisted of: 1) Prioritization of the health problem, 2) Conformation of an interdisciplinary work group, 3) Development of content and systematic search for information 4) Analysis, review and discussion of interventions, 5) Review and validation by regulatory areas, 6) Dissemination and implementation.<br />Conclusions: Promotion and prevention actions must be carried out at all levels and by all health personnel, likewise, the incorporation of new treatments for DM2 in the IMSS, requires the homologation of the criteria in risk stratification, diagnosis, profile risk of hypoglycemia and adverse effects to limit the complications of the disease and reduce the burden of disease (disability and premature death).<br /> (© 2022 Revista Medica del Instituto Mexicano del Seguro Social.)

Published Date